ABVAX | DODGX | ABVAX / DODGX | |
Total Expense Ratio | 0.89 | 0.51 | 175% |
Annual Report Gross Expense Ratio | 0.89 | 0.51 | 175% |
Fund Existence | 24 years | 61 years | - |
Gain YTD | 6.848 | 7.961 | 86% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 440M | 117B | 0% |
Annual Yield % from dividends | 0.97 | 1.38 | 70% |
Returns for 1 year | 0.63 | 6.76 | 9% |
Returns for 3 years | 16.59 | 30.77 | 54% |
Returns for 5 years | 44.48 | 75.02 | 59% |
Returns for 10 years | 37.71 | 62.92 | 60% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RSPE | 28.40 | 0.17 | +0.59% |
Invesco ESG S&P 500 Equal Weight ETF | |||
EUFN | 32.80 | 0.08 | +0.24% |
iShares MSCI Europe Financials ETF | |||
JANW | 35.41 | 0.06 | +0.18% |
AllianzIM US Large Cap Buffer20 Jan ETF | |||
OPER | 100.51 | 0.06 | +0.06% |
ClearShares Ultra-Short Maturity ETF | |||
COWTF | 24.04 | N/A | N/A |
Barclays Bank PLC |